SEC Form 4 · accession 0001237899-15-000056
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael S Brown
Director
Period of report
Dec 10, 2015
Accepted (ET)
Dec 11, 2015 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 10, 2015 | M | 3,000 | $177.82 | A | 3,000 | D | |
| Common Stock | Dec 10, 2015 | S | 100 | $543.55 | D | 2,900 | D | |
| Common Stock | Dec 10, 2015 | S | 100 | $544.03 | D | 2,800 | D | |
| Common StockF2 | Dec 10, 2015 | S | 598 | $545.41 | D | 2,202 | D | |
| Common StockF3 | Dec 10, 2015 | S | 1,003 | $546.36 | D | 1,199 | D | |
| Common StockF4 | Dec 10, 2015 | S | 1,199 | $547.50 | D | 0 | D | |
| Common Stock | holding | — | — | — | 18,349 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F5 | $177.82 | Dec 10, 2015 | M | 3,000 | D | — | Jan 2, 2023 | Common Stock | 3,000 | 12,000 | D |
Explanation of responses
- F1Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- F2Represents volume-weighted average price of sales of 598 shares of Company stock on December 10, 2015 at prices ranging from $545.01 to $545.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2015 at each separate price.
- F3Represents volume-weighted average price of sales of 1,003 shares of Company stock on December 10, 2015 at prices ranging from $546.00 to $546.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2015 at each separate price.
- F4Represents volume-weighted average price of sales of 1,199 shares of Company stock on December 10, 2015 at prices ranging from $547.00 to $547.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2015 at each separate price.
- F5The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.